Axogen, Inc. (AXGN) SEC Filings — 2025
13 SEC filings for Axogen, Inc. (AXGN) in 2025.
Filings
- Axogen Files 8-K: Director Changes & Financials — 8-K · Dec 5, 2025
- Axogen Files 8-K: Regulation FD, Other Events, Exhibits — 8-K · Dec 4, 2025
- Axogen Swings to Profit on Strong Q3 Revenue Growth — 10-Q · Oct 29, 2025
- Axogen's Avance® Nerve Graft Gets FDA Priority Review — 8-K · Aug 25, 2025
- Axogen's Q2 Revenue Jumps 18% Amidst Widening Net Loss — 10-Q · Aug 5, 2025
- Axogen Files 8-K on Shareholder Votes and Financials — 8-K · Jun 20, 2025
- Axogen, Inc. Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Axogen Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
- Axogen, Inc. Files 8-K Report — 8-K · Apr 7, 2025
- Axogen, Inc. Files 8-K Report — 8-K · Mar 4, 2025
- Axogen, Inc. Files 2024 10-K — 10-K · Feb 26, 2025
- Axogen, Inc. Files 8-K on Financials and Reg FD — 8-K · Feb 25, 2025
- Axogen, Inc. Files 8-K on Financials — 8-K · Jan 10, 2025